| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.006 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |